VEGFA and meningioma: Pathologic analysis of components of the VEGF angiogenesis pathway and of tumor microvascular density in meningiomas showed robust expression of SEMA3 (an angiogenesis inhibitor that was not expressed in schwannomas) and in contrast of our findings in schwannomas, there was no correlation between expression of VEGF pathway components and tumor microvascular density in meningiomas.